BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 11343218)

  • 1. Correlates of change in cytomegalovirus viremia in patients with advanced human immunodeficiency virus infection who require transfusion.
    Para MF; Kalish LA; Collier AC; Murphy EL; Drew WL;
    J Infect Dis; 2001 Jun; 183(11):1673-7. PubMed ID: 11343218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of asymptomatic cytomegalovirus viraemia to oral ganciclovir 3 g/day or 6 g/day in HIV-infected patients.
    Grzywacz M; Deayton JR; Bowen EF; Wilson P; Emery VC; Johnson MA; Griffiths PD
    J Med Virol; 1999 Nov; 59(3):323-8. PubMed ID: 10502264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality.
    Durier N; Ananworanich J; Apornpong T; Ubolyam S; Kerr SJ; Mahanontharit A; Ferradini L; Ruxrungtham K; Avihingsanon A
    Clin Infect Dis; 2013 Jul; 57(1):147-55. PubMed ID: 23511301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of highly active antiretroviral therapy on cytomegalovirus viraemia in the absence of specific anti-cytomegalovirus therapy.
    Mihăilescu R; Arama V; Paraschiv S; Streinu-Cercel A; Oţelea D; Munteanu D; Iosipenco M; Chiotan C; Benea OE; Mărdărescu M; Rădulescu M; Hristea A; Ungurianu R; Aramă SS; Cercel AS; Călin R; Băicuş C
    Rom J Intern Med; 2008; 46(4):305-11. PubMed ID: 19480296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS Clinical Trials Group Protocol 360).
    Erice A; Tierney C; Hirsch M; Caliendo AM; Weinberg A; Kendall MA; Polsky B;
    Clin Infect Dis; 2003 Aug; 37(4):567-78. PubMed ID: 12905142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative and quantitative PCR measures of cytomegalovirus in patients with advanced HIV infection who require transfusions.
    Para MF; Kalish LA; Collier AC; Pollard RB; Kumar PN; Mintz L; Wallach FR; Drew WL;
    J Acquir Immune Defic Syndr; 2001 Apr; 26(4):320-5. PubMed ID: 11317072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease of cytomegalovirus replication in human immunodeficiency virus infected-patients after treatment with highly active antiretroviral therapy.
    O'Sullivan CE; Drew WL; McMullen DJ; Miner R; Lee JY; Kaslow RA; Lazar JG; Saag MS
    J Infect Dis; 1999 Sep; 180(3):847-9. PubMed ID: 10438377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation of cytomegalovirus (CMV) DNA by real-time PCR for occurrence of CMV disease in HIV-infected patients receiving highly active antiretroviral therapy.
    Gourlain K; Salmon D; Gault E; Leport C; Katlama C; Matheron S; Costagliola D; Mazeron MC; Fillet AM; ;
    J Med Virol; 2003 Mar; 69(3):401-7. PubMed ID: 12526052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
    Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus viral load testing of blood using quantitative polymerase chain reaction in acutely unwell HIV-1-positive patients lacks diagnostic utility.
    Edwards SG; Grover D; Scott C; Tedder RS; Pillay D; Copas A; Miller RF
    Int J STD AIDS; 2007 May; 18(5):321-3. PubMed ID: 17524192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative cytomegalovirus DNA level in the blood and its relationship to cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
    Tufail A; Moe AA; Miller MJ; Wagar EA; Bruckner DA; Holland GN
    Ophthalmology; 1999 Jan; 106(1):133-41. PubMed ID: 9917794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The status of CMV viral load testing.
    Feinberg J
    AIDS Clin Care; 1996 Oct; 8(10):81. PubMed ID: 11363986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CMV DNA levels and CMV gB subtypes in ART-naive HAART-treated patients: a 2-year follow-up study in The Netherlands.
    Goossens VJ; Wolffs PF; van Loo IH; Bruggeman CA; Verbon A
    AIDS; 2009 Jul; 23(11):1425-9. PubMed ID: 19531930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid progression of HIV disease in children with cytomegalovirus DNAemia.
    Nigro G; Krzysztofiak A; Gattinara GC; Mango T; Mazzocco M; Porcaro MA; Provvedi S; Booth JC
    AIDS; 1996 Sep; 10(10):1127-33. PubMed ID: 8874630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disproportionately high semen shedding of HIV is associated with compartmentalized cytomegalovirus reactivation.
    Sheth PM; Danesh A; Sheung A; Rebbapragada A; Shahabi K; Kovacs C; Halpenny R; Tilley D; Mazzulli T; MacDonald K; Kelvin D; Kaul R
    J Infect Dis; 2006 Jan; 193(1):45-8. PubMed ID: 16323130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a 14-day course of foscarnet on cytomegalovirus (CMV) blood markers in a randomized study of human immunodeficiency virus-infected patients with persistent CMV viremia. Agence National de Recherche du SIDA 023 Study Group.
    Salmon-Céron D; Fillet AM; Aboulker JP; Gérard L; Houhou N; Carrière I; Ostinelli J; Vildé JL; Brun-Vézinet F; Leport C
    Clin Infect Dis; 1999 Apr; 28(4):901-5. PubMed ID: 10825058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
    Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ
    J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of active cytomegalovirus infection in clinically stable HIV-infected individuals with CD4+ lymphocyte counts below 100/microliters of blood: features and relation to risk of subsequent CMV retinitis.
    MacGregor RR; Pakola SJ; Graziani AL; Montzka DP; Hodinka RL; Nichols CW; Friedman HM
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):324-30. PubMed ID: 7552494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.